Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Unjha Formulations Ltd

NSE: UNJHAFOR · BSE: 531762 · Pharmaceuticals & Biotechnology · 17 announcements

Share price
₹31.15
Market cap
₹13.96 Cr
Revenue (annual)
₹15.59 Cr
Net profit (annual)
₹0.70 Cr
P/E (TTM)
29.6×Sector 47.4×
Promoter holding
36.92%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:38 IST BSE
Financial Results

Unjha Formulations Financial Results

Unjha Formulations filed the XBRL/XML financial statements for year ended 31/03/2026 with BSE. The submission includes Balance Sheet, P&L, and Cash Flow under SEBI LODR.

18:43 IST BSE
Other Announcement

Unjha Formulations Other Announcement

Unjha Formulations Limited filed its shareholding distribution schedule as of March 31, 2026, pursuant to SEBI regulations. This is a routine compliance disclosure regarding shareholder distribution.

11:47 IST BSE
Annual General Meeting

Unjha Formulations Annual General Meeting

Unjha Formulations Limited conducted its 32nd Annual General Meeting on August 14, 2026. Members transacted business including the adoption of financial statements and director appointments.

14:44 IST BSE
Annual General Meeting

Unjha Formulations Annual General Meeting

Unjha Formulations Limited has scheduled its Annual General Meeting for August 14, 2026. Agenda items include the adoption of financial statements and related party transactions worth ₹2.00 Crore.

Value
₹2.00 Cr
14:06 IST BSE
Annual General Meeting

Unjha Formulations Annual General Meeting

Unjha Formulations Limited has scheduled its 32nd Annual General Meeting for August 14, 2026. The company fixed August 7, 2026, as the cut-off date for e-voting entitlement.

14:27 IST BSE
Annual Report

Unjha Formulations Annual Report

Unjha Formulations submitted its 32nd Annual Report for FY 2025-26. The report includes a notice for the 32nd Annual General Meeting scheduled for August 14, 2026.

14:02 IST BSE
Annual General Meeting

Unjha Formulations Annual General Meeting

Unjha Formulations Limited has scheduled its 32nd Annual General Meeting for August 14, 2026. The meeting will address financial statements and management appointments.

13:58 IST BSE
Board Meeting Date

Unjha Formulations Board Meeting Date

Unjha Formulations scheduled a board meeting on August 3, 2026. The board will consider unaudited financial results for the quarter ended June 30, 2026.

15:57 IST BSE
Price Movement Clarification

Unjha Formulations Price Movement Clarification

Unjha Formulations clarified that recent share price movements are purely market-driven. The company confirmed it has no undisclosed price-sensitive information affecting performance or operations.

14:20 IST BSE
Annual General Meeting

Unjha Formulations Annual General Meeting

Unjha Formulations Ltd will hold its 32nd Annual General Meeting on 14 August 2026 at Sidhpur, Gujarat. Shareholders are invited to attend as per the notice.

16:14 IST BSE
Board Meeting Outcome

Unjha Formulations Board Meeting Outcome

Unjha Formulations Limited appointed Ms. Khushboo N Patel as Company Secretary and Compliance Officer. The board approved the appointment effective from June 01, 2026.

14:18 IST BSE
Financial Results

Unjha Formulations Financial Results

Unjha Formulations reported a total income of ₹15.75 Crore for FY 2025-26. The board approved audited results with an unmodified auditor opinion during its meeting.

Value
₹15.75 Cr
14:20 IST BSE
Other Announcement

Unjha Formulations Other Announcement

Unjha Formulations Limited submitted a declaration confirming it is not classified as a 'Large Corporate' under SEBI's framework. This filing exempts the company from specific debt-raising requirements mandated for larger entities for the current period.

14:54 IST BSE
Board Meeting Outcome

Unjha Formulations Board Meeting Outcome

Unjha Formulations Limited has scheduled a Board Meeting for May 18, 2026. The agenda includes considering and approving the audited financial results for the quarter and year ended March 31, 2026, and the appointment of a secretarial auditor for FY 2025-26.